Trial intelligence / Profile preview

Vardenafil Efficacy 12-24 Hours Post-Dose in ED

NCT00667979Phase 4Completed

Sponsor
Bayer
Start
Sep 2004
Modality
Small Molecules
01

Overview

A Phase 4 trial of vardenafil in erectile dysfunction (ED), sponsored by Bayer. Started Sep 2004; status: completed.

02

Drugs

vardenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00667979.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00667979.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call